Propanc Biopharma Inc. has announced the appointment of Ms. Jeannine Zimmerman as the company's new Chief Financial Officer, effective August 13, 2025. Ms. Zimmerman brings extensive experience in accounting and financial management, having previously worked with SEC Solutions Group, LLP, and various public and not-for-profit accounting firms across different sectors.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-023580), on August 13, 2025, and is solely responsible for the information contained therein.